BioTuesdays

Author - Abby Hardy

Corindus Logo
Markets

Corindus Vascular Robotics closes private placement

Corindus Vascular Robotics (NYSE American:CVRS) privately sold 10,872,716 of its common shares at a price of $1.3796 each to a large institutional investor for gross proceeds of about $15-million. Net proceeds of about...

February 26, 2019
Pulse Biosciences Logo
Markets

HCW starts Pulse Biosciences at buy; PT $27

H.C. Wainwright launched coverage of Pulse Biosciences (NASDAQ:PLSE) with a “buy” rating and price target of $27. The stock closed at $18.23 on Feb. 22. Analyst Swayampakula Ramakanth writes that his recommendation is...

February 25, 2019
Arcturus Logo
Markets

Roth starts Arcturus Therapeutics at buy; PT $14

Roth Capital Partners launched coverage of Arcturus Therapeutics (NASDAQ:ARCT) with a “buy” rating and $14 price target. The stock closed at $4.84 on Feb. 19. “Arcturus is a hidden gem in a sea of RNA medicines...

February 20, 2019
Inventiva
Markets

HCW starts Inventiva at buy: PT €19

H.C. Wainwright initiated coverage of France-based Inventiva (PSE:IVA) with a “buy” rating and price target of €19. The stock closed at €6.40 on Feb. 12. Inventiva was spun out of Abbott Labs in 2012 and is focused on...

February 13, 2019
Mesoblast Logo
Markets

HCW assumes coverage of Mesoblast at buy; PT $6.50

H.C. Wainwright analyst Swayampakula Ramakanth assumed coverage of Mesoblast (NASDAQ:MESO) with a “buy” rating and price target of $6.50. The stock closed at $4.56 on Jan. 30. Australia-based Mesoblast is focused on...

January 31, 2019